Work

N9741: FOLFOX (oxaliplatin(Oxal)/ 5-fluorouracil (5-FU)/ leucovorin (LV) or reduced dose R-IFL (CPT-11 + 5-FU/LV) in advanced colorectal cancer (CRC): Final efficacy data from an intergroup study

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.3621

Authors: R. M. Goldberg, D. J. Sargent, R. F. Morton, C. Fuchs, R. K. Ramanathan, S. K. Williamson, B. P. Findlay, H. R. Pitot, S. R. Alberts

Institutions: University of North Carolina at Chapel Hill, Mayo Clinic, University of Kansas, University of Pittsburgh, Dana-Farber Cancer Institute, Iowa Oncology Research Association

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2294798321

Cites:

Cited by: 70

Related to: 10